-
FDA Approves Kisqali for Early-Stage Breast Cancer
FDA Approves Kisqali for Early-Stage Breast Cancer September 17, 2024 Kisqali (chemical name: ribociclib) can now be used after surgery in combination with an aromatase inhibitor to treat stage II or stage III hormone receptor-positive, HER2-negative breast cancer with a high risk of recurrence. Read more…
-
Testing for ESR1 Mutations, Then Switching to Camizestrant Improves Outcomes for HR+ HER2- MBC
Testing for ESR1 Mutations, Then Switching to Camizestrant Improves Outcomes for Metastatic HR+ HER2- Breast Cancer May 31, 2025 After two years of follow-up, the new treatment improved survival and quality of life. Read more…
-
New Hormonal Therapy Vepdegestrant Promising for Some Metastatic HR+ Breast Cancers
New Hormonal Therapy Vepdegestrant Promising for Some Metastatic HR+ Breast Cancers May 30, 2025 The new medicine offered more benefits than Faslodex. Read more…
-
Trodelvy and Keytruda as First Treatment for Metastatic TNBC: A New Standard of Care?
Trodelvy and Keytruda as First Treatment for Metastatic TNBC: A New Standard of Care? May 30, 2025 People lived longer without the cancer growing when they received Trodelvy and Keytruda compared to the current standard treatment. Read more…
-
Camrelizumab Seems Promising As New Triple-Negative Breast Cancer Treatment
Camrelizumab Seems Promising As New Triple-Negative Breast Cancer Treatment Apr 14, 2025 Adding the immunotherapy medicine camrelizumab to chemotherapy offered better outcomes than chemotherapy alone for TNBC. Read more…
-
Enhertu Plus Perjeta: New First-Line Treatment for Metastatic HER2-Positive Breast Cancer?
Enhertu Plus Perjeta: New First-Line Treatment for Metastatic HER2-Positive Breast Cancer? Jun 1, 2025 The combination offered better outcomes than the THP chemo regimen. Read more…
-
Breaking Research News from Breastcancer.org
Breastcancer.org strives to bring you updates on the latest breast cancer research through its Research News program. Medical experts at Breastcancer.org provide easy-to-understand summaries of what the research means for YOU. Favorite this thread to get notifications on all the breaking news about current breast cancer…
-
Breastcancer.org Reports on ASCO 2025
Follow our breaking news page on Breast Cancer Research Highlights From ASCO 2025 Stay tuned as we update the news in the thread below!
-
Adding Cannabis to Standard Medicines Offers Better Nausea Control for People With Cancer
Adding Cannabis to Standard Medicines Offers Better Nausea Control for People With Cancer Sep 9, 2024 But there’s a tradeoff: People taking cannabis reported feeling more anxious and dizzy than people who didn’t take cannabis. Read more…
-
Mindfulness Practices Recommended for Anxiety, Depression in People With Cancer
Mindfulness Practices Recommended for Anxiety, Depression in People With Cancer Sept 5, 2023 Two professional cancer organizations have formally recommended mindfulness practices to ease anxiety and depression in people diagnosed with cancer. Read more…
-
Should Doctors Regularly Screen for Breast Cancer Brain Metastases?
Should Doctors Regularly Screen for Breast Cancer Brain Metastases? Mar 5, 2025 Research suggests current screening guidelines for brain mets need updating. Read more…
-
Breast Cancer Survivors With BRCA Mutation Have Higher Risk of Second Cancer
Breast Cancer Survivors With BRCA Mutation Have Higher Risk of Second Cancer Jan 16, 2025 Risks were higher for a new cancer in the opposite breast, as well as ovarian, pancreatic, and prostate cancers. Read more…
-
After Early-Stage Breast Cancer, Risk of Metastatic Recurrence Higher for Younger People
After Early-Stage Breast Cancer, Risk of Metastatic Recurrence Higher for Younger People Jan 16, 2025 Some breast cancers may be more likely to come back as metastatic disease five to 10 years after surgery in people ages 35 and younger. Read more…
-
One Chemo Medicine Before Surgery for Early-Stage HER2-Positive Breast Cancer May Be Better Than Two
One Chemo Medicine Before Surgery for Early-Stage HER2-Positive Breast Cancer May Be Better Than Two Feb 5, 2025 Abraxane instead of Taxotere and carboplatin led to a better response and fewer serious side effects. Read more…
-
Adding MRI to 3D Mammograms May Save Lives of Women With Extremely Dense Breasts
Adding MRI to 3D Mammograms May Save Lives of Women With Extremely Dense Breasts Sep 25, 2024 While the benefits of supplemental screening are clear, the additional screenings may also lead to more false alarms, which can take a financial and emotional toll on people. Read more…
-
Active Monitoring May Be as Good as Surgery for Low-Risk DCIS
Active Monitoring May Be as Good as Surgery for Low-Risk DCIS Dec 20, 2024 Two-year rates of invasive cancer were similar for women whether they had surgery or frequent mammograms, but more research is needed. Read more…
-
Breastcancer.org News Hub
Check out our reporting on trending breast cancer news in our one-of-a-kind and frequently updated News Hub:
-
Imlunestrant Plus Verzenio: New Treatment Option for Certain Hormonal Therapy-Resistant Breast Cance
Imlunestrant Plus Verzenio: New Treatment Option for Certain Hormonal Therapy-Resistant Breast Cancers? Dec 20, 2024 Combined with Verzenio, this new oral SERD may be a good option for advanced-stage breast cancer with an ESR1 mutation. Read more…
-
Adding Ibrance Stops Growth of Metastatic Triple-Positive Disease for More Than a Year
Adding Ibrance Stops Growth of Metastatic Triple-Positive Disease for More Than a Year Dec 18, 2024 Progression-free survival was 15 months longer when Ibrance was added to standard treatment. Read more…
-
After surgery can drink Soybean milk everyday?
pr90%,er90%,hers-,after surgery ,can drink soybean milk everyday?is that harmful ?soybean milk can form Estrogen?
-
Metastatic Recurrence Risk After Early-Stage Breast Cancer Drops
Metastatic Recurrence Risk After Early-Stage Breast Cancer Drops Nov 14, 2024 Treatments after surgery are more effective today and studies now include more women with lower-risk disease. Read more…
-
Hormonal Birth Control Ups Breast Cancer Risk in Women With BRCA1 Mutations
Hormonal Birth Control Ups Breast Cancer Risk in Women With BRCA1 Mutations Oct 23, 2024 The longer women with the mutation used hormonal contraception, the bigger the increase in risk. Read more…
-
High-Intensity Exercise During Chemotherapy for Breast Cancer Improves Survival
High-Intensity Exercise During Chemotherapy for Breast Cancer Improves Survival September 18, 2024 Women who did a combination of high-intensity interval training, plus either strength work or moderate-intensity aerobic exercise, during chemotherapy for early-stage breast cancer were more likely to be alive and less likely…
-
Hormonal Therapy for Breast Cancer May Lower Dementia Risk in Older Women
Hormonal Therapy for Breast Cancer May Lower Dementia Risk in Older Women Sep 9, 2024 Protection varied by race and decreased with age. Read more…
-
Remembering Shannen Doherty: Her Breast Cancer Story
Remembering Shannen Doherty: Her Breast Cancer Story July 19, 2024 Through her podcast, social media, and openness with the media, Doherty offered the public an intimate look at her experience with breast cancer that spread to her brain. Read more…
-
Keytruda Improves Survival in Triple-Negative Breast Cancer
Keytruda Improves Survival in Triple-Negative Breast Cancer September 15, 2024 People diagnosed with early-stage triple-negative breast cancer who received the immunotherapy Keytruda (chemical name: pembrolizumab) along with chemotherapy before and after surgery had better event-free survival — how long they lived without…
-
Breastfeeding After Breast Cancer Treatment Seems Safe
Breastfeeding After Breast Cancer Treatment Seems Safe September 14, 2024 Women — including women with a BRCA mutation — who breastfeed after receiving breast cancer treatment don’t have a higher risk of recurrence (the cancer coming back) or of a new breast cancer, according to two international studies presented on Sept.…
-
HER2-Positive Brain Mets Respond to Enhertu
HER2-Positive Brain Mets Respond to Enhertu September 12, 2014 The targeted therapy Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) helped control areas of metastatic HER2-positive breast cancer in the brain, according to results from the DESTINY-Breast12 study presented on Sept. 13 at ESMO 2024. Read more…
-
New Hormone-Free Hot Flash Treatments
New Hormone-Free Hot Flash Treatments August 14, 2024 Hot flashes can dramatically affect some women’s quality of life. New research shows hormone-free options can offer relief. Read more…
-
Got Prunes? Fruit Linked to Better Bone Health
Got Prunes? Fruit Linked to Better Bone Health August 16, 2024 Eating about six prunes a day can help maintain bone density and strength. Read more…